Literature DB >> 27890374

Clinical significance of dynamic detection for serum levels of MCP-1, TNF-α and IL-8 in patients with acute pancreatitis.

Yuan-Zheng Yang1, Ying Xiang2, Mian Chen3, Li-Na Xian3, Xiao-Yan Deng3.   

Abstract

OBJECTIVE: To observe dynamic changes of levels of monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-α (TNF-α) and interleukin-8 (IL-8) in patients with acute pancreatitis and to investigate its evaluation value on the severity of acute pancreatitis.
METHODS: A total of 109 patients with acute pancreatitis admitted were divided into mild acute pancreatitis group (MAP group, 42 cases), moderately severe acute pancreatitis (MSAP group, 35 cases) and severe acute pancreatitis (SAP group, 32 cases). ELISA was used to detect the serum levels of MCP-1, TNF-α and IL-8 of patients at day 1, day 4 and day 7 of admission to hospital.
RESULTS: The serum levels of MCP-1, TNF-α and IL-8 from MAP group, MSAP group and SAP group at day 1 of admission to hospital all significantly increased. There was a significant difference between MAP group and control group, MSAP group and MAP group, SAP group and MSAP group (P < 0.05). The serum concentrations of IL-8 from MASP group and SAP group obviously increased at day 1, and there was significant difference between MASP group and MAP group, SAP group and MSAP group (P < 0.05), while the difference between MAP group and control group was not obvious (P > 0.05); The serum concentrations of MCP-1, TNF-α and IL-8 from MAP group all reached the highest level at day 4, which were significantly higher than the detection levels at day 1. In MSAP group and SAP group, the serum concentrations of MCP-1, TNF-α and IL-8 were the highest at day 1, which were significantly higher than the detection levels at day 4 and 7. At each detecting timing, the serum concentrations of MCP-1, TNF-α and IL-8 from MSAP group and SAP group were all higher than those of MAP group and MSAP group, respectively.
CONCLUSIONS: The dynamic changes of serum levels of MCP-1, TNF-α and IL-8 in patients with acute pancreatitis have their rules, and the change rule of MAP group was different with that of MSAP and SAP group, which showed the reference value for the diagnosis and illness severity evaluation of acute pancreatitis. Copyright Â
© 2016 Hainan Medical University. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Interleukin-8; Monocyte chemotactic protein-1; Pancreatitis; Tumor necrosis factor-α

Year:  2016        PMID: 27890374     DOI: 10.1016/j.apjtm.2016.09.001

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  5 in total

1.  Dynamic Monitoring of Immunoinflammatory Response Identifies Immunoswitching Characteristics of Severe Acute Pancreatitis in Rats.

Authors:  Qian Zhuang; Liqiang Huang; Yue Zeng; Xu Wu; Gan Qiao; Minghua Liu; Lulu Wang; Yejiang Zhou; Yuxia Xiong
Journal:  Front Immunol       Date:  2022-05-19       Impact factor: 8.786

2.  Emodin Attenuates Severe Acute Pancreatitis via Antioxidant and Anti-inflammatory Activity.

Authors:  Shilin Xia; Yujia Ni; Qi Zhou; Han Liu; Hong Xiang; Hua Sui; Dong Shang
Journal:  Inflammation       Date:  2019-12       Impact factor: 4.657

3.  Assessment of acute pancreatitis severity via determination of serum levels of hsa-miR-126-5p and IL-6.

Authors:  Ying-Jie Chen; Tian-Lai Lin; Zhe Cai; Chang-Hu Yan; Sen-Ren Gou; Yao-Dong Zhuang
Journal:  Exp Ther Med       Date:  2020-11-09       Impact factor: 2.447

4.  An immune-modulating formula comprising whey peptides and fermented milk improves inflammation-related remote organ injuries in diet-induced acute pancreatitis in mice.

Authors:  Kentaro Nakamura; Kazuhiko Fukatsu; Akina Sasayama; Taketo Yamaji
Journal:  Biosci Microbiota Food Health       Date:  2017-08-25

Review 5.  Comprehensive Mechanism, Novel Markers and Multidisciplinary Treatment of Severe Acute Pancreatitis-Associated Cardiac Injury - A Narrative Review.

Authors:  YaLan Luo; ZhaoXia Li; Peng Ge; HaoYa Guo; Lei Li; GuiXin Zhang; CaiMing Xu; HaiLong Chen
Journal:  J Inflamm Res       Date:  2021-07-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.